CONAGEN DISCLOSES ANTIOXIDANT KAEMPFEROL DEVELOPMENT BY PRECISION FERMENTATION
KUALA LUMPUR, Jan 6 (Bernama) -- Conagen, the Massachusetts-based biotechnology innovator, has announced the successful development of antioxidant kaempferol produced by state-of-the-art, proprietary, precision fermentation.
Conagen’s kaempferol enables brands in nutrition, beauty, and personal care products to adopt a more natural position by formulating with clean and sustainable kaempferol, according to a statement.
Recognised as one of nature’s most potent antioxidants, kaempferol is a flavonoid with health-promoting properties found in tea, fruits, and vegetables, especially rich in green leafy vegetables such as spinach and kale.
Rising consumer awareness towards chronic diseases such as cancer and diabetes drives the kaempferol market demand. The global kaempferol market may exceed US$6.5 billion by 2025, according to a recent research report by Global Market Insights Inc. (US$1 = RM4.197)
“We’re bringing to market a pure and natural kaempferol at affordable prices that were not possible or available until now,” said vice president of innovation at Conagen, Casey Lippmeier, Ph.D.
“Conagen’s scalable, precision fermentation for producing flavonoids like kaempferol is more efficient and sustainable than what can be achieved with the chemically-synthesised or botanically-sourced molecule.”
Dietary kaempferol in multiple studies has demonstrated a wide range of promising beneficial activities, primarily as an anti-inflammatory and antioxidant, for reducing the risk of chronic diseases, especially cancer.
Conagen derived kaempferol from its molecular platform for flavonoid antioxidants, including the previously announced molecules: DHQ, also known as Taxifolin, p-coumaric acid, hydroxytyrosol, and rosmarinic acid.
The development of natural kaempferol is good news for Conagen’s commercialisation partner, Blue California, as kaempferol will expand its offerings of specialty ingredient solutions.
More details at www.conagen.com.
-- BERNAMA
Comments